Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengli Jiang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 21, 2026
Letter to the Editor: "Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis"Chengli Jiang
European Journal of Endocrinology|April 15, 2026
Re-evaluating GLP-1 receptor agonist-associated changes in copeptinChengli Jiang, Gang Tian
International Wound Journal|September 22, 2023
The role of programmed cell death in diabetic foot ulcersJuncheng Li, Chengli Jiang, Jian Xia
Cancer Management and Research|March 27, 2025
The Role of AHCY Expression in Bladder Urothelial Carcinoma: A Bioinformatics and Experimental AnalysisShaorui Niu, Xiaozhe Zheng, Yuyang Yao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 8, 2025
Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaquesLin Shen, Chengli Jiang, Jingjing Song, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2025
Corrigendum to 'Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques' [Journal of Controlled Release 385 (2025) 114000]Lin Shen, Chengli Jiang, Jingjing Song, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 23, 2025
PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic ReprogrammingLin Shen, Junchao Yu, Weiqian Chen, et al.
Cell Death Discovery|April 13, 2026
NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancerShaorui Niu, Pang Yang, Yuyang Yao, et al.
Lipids in Health and Disease|October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinomaYanran Bi, Xihui Ying, Wanbin Chen, et al.
Quantitative Imaging in Medicine and Surgery|February 11, 2026
Prediction of stroke events in patients with type 2 diabetes mellitus by interpretable machine learning based on perivascular adipose tissue features: a multicenter cohort studyTing Zhao, Guihan Lin, Weiyue Chen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 21, 2026
Letter to the Editor: "Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis"Chengli Jiang
European Journal of Endocrinology|April 15, 2026
Re-evaluating GLP-1 receptor agonist-associated changes in copeptinChengli Jiang, Gang Tian
International Wound Journal|September 22, 2023
The role of programmed cell death in diabetic foot ulcersJuncheng Li, Chengli Jiang, Jian Xia
Cancer Management and Research|March 27, 2025
The Role of AHCY Expression in Bladder Urothelial Carcinoma: A Bioinformatics and Experimental AnalysisShaorui Niu, Xiaozhe Zheng, Yuyang Yao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 8, 2025
Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaquesLin Shen, Chengli Jiang, Jingjing Song, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2025
Corrigendum to 'Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques' [Journal of Controlled Release 385 (2025) 114000]Lin Shen, Chengli Jiang, Jingjing Song, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 23, 2025
PPP1R3B Suppresses Atherosclerosis by Promoting the M2 Polarization of Macrophages Through Glycogen Metabolic ReprogrammingLin Shen, Junchao Yu, Weiqian Chen, et al.
Cell Death Discovery|April 13, 2026
NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancerShaorui Niu, Pang Yang, Yuyang Yao, et al.
Lipids in Health and Disease|October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinomaYanran Bi, Xihui Ying, Wanbin Chen, et al.
Quantitative Imaging in Medicine and Surgery|February 11, 2026
Prediction of stroke events in patients with type 2 diabetes mellitus by interpretable machine learning based on perivascular adipose tissue features: a multicenter cohort studyTing Zhao, Guihan Lin, Weiyue Chen, et al.
Pageof 1